Doxorubicin in P-glycoprotein-targeting pluronics(Christie Hospital Nhs Foundation Trust)

N/A

Report date: 2024/09/04 17:41:17

Base Information

Drug NameDoxorubicin in P-glycoprotein-targeting pluronics(Christie Hospital Nhs Foundation Trust)
Drug Alias NameDoxorubicin SP1000(Supratek Pharma)SP1049C
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTopoisomerase II inhibitorsDNA intercalators
TargetsTopoisomerase IIDNA
Therapy Area/IndicationsEsophageal adenocarcinomaEsophageal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesChristie Hospital Nhs Foundation TrustSupratek Pharma
China Registration ClassN/A

Develop Information

Active CompaniesChristie Hospital Nhs Foundation Trust
Inactive CompaniesN/A
Active IndicationsEsophageal adenocarcinomaEsophageal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A